EMEIS SA (EMEIS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EMEIS - FR001400NLM4 - Common Stock
14.05 EUR
+0.77 (+5.8%)
We assign a fundamental rating of 1 out of 10 to EMEIS. EMEIS was compared to 29 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of EMEIS have multiple concerns. EMEIS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
EMEIS had negative earnings in the past year.
EMEIS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EMEIS reported negative net income in multiple years.
In the past 5 years EMEIS always reported a positive cash flow from operatings.
1.2 Ratios
EMEIS has a Return On Assets of -3.07%. This is amonst the worse of the industry: EMEIS underperforms 89.66% of its industry peers.
With a Return On Equity value of -23.89%, EMEIS is not doing good in the industry: 89.66% of the companies in the same industry are doing better.
EMEIS has a Return On Invested Capital of 0.03%. This is amonst the worse of the industry: EMEIS underperforms 86.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROIC | 0.03% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EMEIS's Operating Margin of 0.08% is on the low side compared to the rest of the industry. EMEIS is outperformed by 86.21% of its industry peers.
In the last couple of years the Operating Margin of EMEIS has declined.
The Profit Margin and Gross Margin are not available for EMEIS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
EMEIS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, EMEIS has more shares outstanding
Compared to 5 years ago, EMEIS has less shares outstanding
EMEIS has a worse debt/assets ratio than last year.
2.2 Solvency
EMEIS has an Altman-Z score of 0.62. This is a bad value and indicates that EMEIS is not financially healthy and even has some risk of bankruptcy.
EMEIS has a Altman-Z score of 0.62. This is in the lower half of the industry: EMEIS underperforms 75.86% of its industry peers.
EMEIS has a debt to FCF ratio of 51.23. This is a negative value and a sign of low solvency as EMEIS would need 51.23 years to pay back of all of its debts.
EMEIS's Debt to FCF ratio of 51.23 is on the low side compared to the rest of the industry. EMEIS is outperformed by 75.86% of its industry peers.
A Debt/Equity ratio of 4.80 is on the high side and indicates that EMEIS has dependencies on debt financing.
With a Debt to Equity ratio value of 4.80, EMEIS is not doing good in the industry: 82.76% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Altman-Z | 0.62 |
ROIC/WACC0.01
WACC4.92%
2.3 Liquidity
EMEIS has a Current Ratio of 0.62. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.
EMEIS's Current ratio of 0.62 is on the low side compared to the rest of the industry. EMEIS is outperformed by 86.21% of its industry peers.
EMEIS has a Quick Ratio of 0.62. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.62, EMEIS is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
EMEIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.53%.
EMEIS shows a small growth in Revenue. In the last year, the Revenue has grown by 6.30%.
The Revenue has been growing by 8.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
3.2 Future
Based on estimates for the next years, EMEIS will show a very strong growth in Earnings Per Share. The EPS will grow by 24.84% on average per year.
The Revenue is expected to grow by 2.70% on average over the next years.
EPS Next Y27.85%
EPS Next 2Y25.35%
EPS Next 3Y23.95%
EPS Next 5Y24.84%
Revenue Next Year5.77%
Revenue Next 2Y5.13%
Revenue Next 3Y4.87%
Revenue Next 5Y2.7%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for EMEIS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMEIS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EMEIS is valued more expensive than 82.76% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EMEIS is valued a bit cheaper than 62.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13 | ||
| EV/EBITDA | 22.19 |
4.3 Compensation for Growth
A more expensive valuation may be justified as EMEIS's earnings are expected to grow with 23.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.35%
EPS Next 3Y23.95%
5. Dividend
5.1 Amount
EMEIS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:EMEIS (12/8/2025, 5:29:57 PM)
14.05
+0.77 (+5.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.04%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap2.27B
Revenue(TTM)5.77B
Net Income(TTM)-412.06M
Analysts75.38
Price Target13.77 (-1.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.27%
PT rev (3m)11.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.51%
EPS NY rev (3m)4.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.87%
Revenue NY rev (3m)0.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.4 | ||
| P/FCF | 13 | ||
| P/OCF | 4.81 | ||
| P/B | 1.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.19 |
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.96
Fwd EYN/A
FCF(TTM)1.08
FCFY7.69%
OCF(TTM)2.92
OCFY20.81%
SpS34.91
BVpS10.68
TBVpS-7.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROCE | 0.04% | ||
| ROIC | 0.03% | ||
| ROICexc | 0.03% | ||
| ROICexgc | 0.04% | ||
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 3.1% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-77.23%
ROICexgc growth 5Y-61.49%
ROICexc growth 3Y-76.08%
ROICexc growth 5Y-60.94%
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Debt/EBITDA | 17.9 | ||
| Cap/Depr | 64.95% | ||
| Cap/Sales | 5.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.08% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 0.62 |
F-Score4
WACC4.92%
ROIC/WACC0.01
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.82%
Cap/Sales(5y)13.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
EPS Next Y27.85%
EPS Next 2Y25.35%
EPS Next 3Y23.95%
EPS Next 5Y24.84%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
Revenue Next Year5.77%
Revenue Next 2Y5.13%
Revenue Next 3Y4.87%
Revenue Next 5Y2.7%
EBIT growth 1Y103.51%
EBIT growth 3Y-77.35%
EBIT growth 5Y-61.53%
EBIT Next Year10760.5%
EBIT Next 3Y419.02%
EBIT Next 5Y255.33%
FCF growth 1Y293.3%
FCF growth 3YN/A
FCF growth 5Y14.58%
OCF growth 1Y28.92%
OCF growth 3Y-14.44%
OCF growth 5Y-10.16%
EMEIS SA / EMEIS.PA FAQ
What is the ChartMill fundamental rating of EMEIS SA (EMEIS.PA) stock?
ChartMill assigns a fundamental rating of 1 / 10 to EMEIS.PA.
What is the valuation status for EMEIS stock?
ChartMill assigns a valuation rating of 2 / 10 to EMEIS SA (EMEIS.PA). This can be considered as Overvalued.
What is the profitability of EMEIS stock?
EMEIS SA (EMEIS.PA) has a profitability rating of 1 / 10.
Can you provide the financial health for EMEIS stock?
The financial health rating of EMEIS SA (EMEIS.PA) is 0 / 10.
Can you provide the dividend sustainability for EMEIS stock?
The dividend rating of EMEIS SA (EMEIS.PA) is 0 / 10 and the dividend payout ratio is 0%.